A) Geodon B) Zyprexa C) Risperdal D) Prolixin
A) Invega B) Zyprexa C) Abilify D) Clozaril
A) Seroquel B) Zyprexa C) Abilify D) Invega
A) Abilify B) Zyprexa C) Risperdal D) Seroquel
A) Geodon B) Seroquel C) Abilify D) Risperdal
A) Olanzapine B) Clozapine C) Ziprasidone D) Quetiapine
A) Aripriprazole B) Risperidone C) Ziprasidone D) Paliperidone
A) Seroquel B) Clozaril C) Risperdal D) Geodon
A) Aripiprazole B) Clozapine C) Paliperidone D) Ziprasidone
A) Olazapine B) Risperdone C) Quetiapine D) Paliperidone
A) Clozapine and Risperadone B) Risperidone and Paliperidone C) Aripiprazole and Paliperidone D) Clozapine and Aripiprazole
A) 1-3 B) 4-5 C) 1 D) 2-5
A) 18 B) 24 C) 12 D) 6
A) TRUE B) FALSE
A) Foster patients' medication compliance B) Develop more adaptive coping skills C) Prevent relapse into another psychotic episode D) Minimize side effects of medication
A) one year after discontinuation of medication B) directly after discontinuation of medication C) six months after discontinuation of medication D) several weeks after discontinuation of medication
A) Symmetrel B) Artane C) Clozaril D) Thorazine
A) weight gain more common B) increased effectiveness for positive, negative, and disorganized symptoms C) enhanced efficacy in treatment-resistant patients D) tardive dyskinesia more common
A) Clozapine B) Prochlorperazine C) Risperidone D) Haloperiodol
A) Anticonvulsants B) Stimulants C) Anxiolitics D) Alcohol
A) Merperidine B) Alcohol C) Halperiodol D) Beta blockers
A) Beta blockers B) Antacids C) Anticonvulsants D) Nicotine
A) Alcohol B) SSRIs C) Tricyclic antidepressants D) Beta blockers
A) FALSE B) TRUE
A) Tobacco use B) Male gender C) Drug holidays D) Alcohol use
A) TRUE B) FALSE
A) All antipsychotic drugs but Clozapine present a significant risk for the development of tardive dyskinesia. B) The more frequent the dose of the antipsychotic medication, the greater the risk for the development of tardive dyskinesia. C) Classic antipsychotic medications present less risk for the development of tardive dyskinesia than atypical antipsychotic medications. D) High potency antipsychotic drugs present greater risk for the development of tardive dyskinesia.
A) Akinesia B) Akathesia C) Acute dystonia D) Ataxia
A) Agranulocytosis B) Neuroleptic Malignant Syndrome C) Gynecomastia D) Postural hypotension
A) TRUE B) FALSE
A) FALSE B) TRUE
A) agonize the normal dopamine-mediated inhibition of prolactin release. B) block D2 receptors in the pituitary gland and inhibit prolactin secretion. C) antagonize the normal dopamine-mediated inhibition of prolactin release. D) block D2 receptors in the pituitary gland and decrease prolactin secretion.
A) receptor binding and DA turnover B) hungry hungry hippos C) neuroendocrine changes D) molecular structure
A) Phenothiazines B) Butyrophenones C) Thioxanthenenes D) Sleepykoaladones
A) Potent; low; lower B) Potent; low; higher C) Weak; high; higher D) Weak; high; lower
A) Anhedonia B) Formal thought disorder C) Hallucinations D) Delusions
A) All of the above B) Endocrine disorders C) Metabolic disorders D) Neurological disorders E) Autoimmune diseases
A) Alcohol B) Hallucinogens C) Opioids D) All of the above E) Stimulants
A) FALSE B) TRUE
A) All of the above. B) disorganized symptoms of Schizophrenia. C) negative symptoms of Schizophrenia. D) positive symptoms of Schizophrenia.
A) blocking pre-synaptic dopamine receptors and/or inhibiting dopamine reuptake. B) blocking post-synaptic dopamine receptors and/or inhibiting dopamine reuptake. C) blocking post-synaptic dopamine receptors and/or inhibiting dopamine release. D) blocking pre-synaptic dopamine receptors and/or inhibiting dopamine release.
A) the drug reduces the normal dopamine-mediated activity in the striatum, which then reduces the cholinergic response that is normally inhibited by dopamine. B) the drug reduces the normal dopamine-mediated activity in the striatum, which then enhances the cholinergic response that is normally inhibited by dopamine. C) the drug increases the normal dopamine-mediated activity in the striatum, which then reduces the cholinergic response that is normally inhibited by dopamine. D) the drug increases the normal dopamine-mediated activity in the striatum, which then enhances the cholinergic response that is normally inhibited by dopamine.
A) increased rates of synthesis B) increased release of dopamine C) increased rates of firing D) increased tap dancing
A) aliphatics B) piperazines C) piperideines D) thioxanthenes
A) menstrual irregularity B) all of the above C) genecomastia D) galactorrhea
A) Symmetrel (amantadine) B) Cogentin (benztropine) C) Artane (trihexphenidyl) D) Inapsine (droperiodol) E) Benadryl (diphenhydramine)
A) FALSE B) TRUE
A) superior impact on positive symptoms B) actual impact at the biological level C) polypharmacy D) comparative lack of EPS
A) Clozaril B) Invega C) Haldol D) Abilify
A) Clorazil B) Risperdal C) Seroquel D) Geodon |